Rowlandmiller & Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $158K | Sell |
|
|||||
|
2025
Q2 | $159K | Sell |
|
|||||
|
2025
Q1 | $163K | Sell |
|
|||||
|
2024
Q4 | $280K | Sell |
|
|||||
|
2024
Q3 | $295K | Sell |
|
|||||
|
2024
Q2 | $267K | Sell |
|
|||||
|
2024
Q1 | $364K | Sell |
|
|||||
|
2023
Q4 | $346K | Sell |
|
|||||
|
2023
Q3 | $391K | Sell |
|
|||||
|
2023
Q2 | $465K | Sell |
|
|||||
|
2023
Q1 | $700K | Sell |
|
|||||
|
2022
Q4 | $725K | Hold |
|
|||||
|
2022
Q3 | $716K | Buy |
|
|||||
|
2022
Q2 | $818K | Buy |
|
|||||
|
2022
Q1 | $888K | Buy |
|
|||||
|
2021
Q4 | $1.01M | Buy |
|
|||||
|
2021
Q3 | $299K | Sell |
|
|||||
|
2021
Q2 | $861K | Buy |
|
|||||
|
2021
Q1 | $698K | Buy |
|
|||||
|
2020
Q4 | $542K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $299K | Buy |
|